Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
ELISA Kit for Urotensin 2 (UST2)
UII; U-II; UCN2; PRO1068; Urotensin-II
- Product No.CEA362Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample TypeSerum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodCompetitive Inhibition
- Assay Length2h
- Detection Range12.35-1,000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 4.96pg/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 441
For more details, please contact local distributors! US$ 630 US$ 2835 US$ 5355 US$ 44100
Specificity
This assay has high sensitivity and excellent specificity for detection of Urotensin 2 (UST2).
No significant cross-reactivity or interference between Urotensin 2 (UST2) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Urotensin 2 (UST2) and the recovery rates were calculated by comparing the measured value to the expected amount of Urotensin 2 (UST2) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 79-96 | 78 |
EDTA plasma(n=5) | 84-102 | 94 |
heparin plasma(n=5) | 84-95 | 90 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Urotensin 2 (UST2) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Urotensin 2 (UST2) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Urotensin 2 (UST2) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 80-98% | 94-102% | 85-99% | 83-95% |
EDTA plasma(n=5) | 98-105% | 93-105% | 78-105% | 93-105% |
heparin plasma(n=5) | 84-97% | 95-103% | 85-98% | 89-101% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1 | Assay Diluent A | 1×12mL |
Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
Reagent Diluent | 1×300µL | Stop Solution | 1×6mL |
TMB Substrate | 1×9mL | Instruction manual | 1 |
Wash Buffer (30 × concentrate) | 1×20mL |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
And then add 50µL prepared Detection Reagent A immediately.
Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
7. Add 50µL Stop Solution. Read at 450 nm immediately.
GIVEAWAYS
INCREMENT SERVICES
Magazine | Citations |
Clinical and Experimental Hypertension | Serum Urotensin II Levels in Patients with Non-Dipper Hypertension Pubmed: 23301552 |
Peptides | Urotensin II (U-II), a novel cyclic peptide, possibly associated with the pathophysiology of osteoarthritis Pubmed: 24468547 |
journal of diabetes and its complications | Urotensin-II level and its association with oxidative stress in early diabetic nephropathy. pubmed:25179234 |
Evidence-based Complementary and Alternative Medicine | Acute Biochemical, Cardiovascular, and Autonomic Response to Hyperbaric (4 atm) Exposure in Healthy Subjects Pubmed:29977313 |
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS | The Relationship of the Urotensin-2 Level in the Aqueous Humor with Systemic Diseases and Pupil Size: Comparative Study Pubmed: 33147089 |
Boy kısalığı olan çocukların serum ürotensin 2 düzeylerinin igf-1 ile ilişkisi. |
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
RPA362Hu01 | Recombinant Urotensin 2 (UST2) | Positive Control; Immunogen; SDS-PAGE; WB. |
CPA362Hu21 | OVA Conjugated Urotensin 2 (UST2) | Immunogen; SDS-PAGE; WB. |
CPA362Hu31 | KLH Conjugated Urotensin 2 (UST2) | Immunogen; SDS-PAGE; WB. |
PAA362Hu01 | Polyclonal Antibody to Urotensin 2 (UST2) | WB; IHC; ICC; IP. |
PAA362Hu08 | Polyclonal Antibody to Urotensin 2 (UST2) | WB; IHC; ICC; IP. |
LAA362Hu71 | Biotin-Linked Polyclonal Antibody to Urotensin 2 (UST2) | WB; IHC; ICC. |
MAA362Hu22 | Monoclonal Antibody to Urotensin 2 (UST2) | WB; IHC; ICC; IP. |
CEA362Hu | ELISA Kit for Urotensin 2 (UST2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA362Hu | Multiplex Assay Kit for Urotensin 2 (UST2) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |